/biz/ - Business & Finance

>>56018575
>Luckily for those in the biotechnology sector, however, is that biotech is working on problems that are changing the world and saving lives. What this means is that despite economic volatility and downturn, people still need to buy their medicine.
Extremely retarded take, small/mid cap R&D isn't like Bayer selling pills. Doesn't seem like biotech performance has all that much to do with whether we're in a recession or not, seems more like a megacycle.